TrialJournal of clinical hypertension (Greenwich, Conn.)2011

Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.

Richard F Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.